• linkedin
  • Increase Font
  • Sharebar

    ASCO endorses prostate Ca active surveillance guideline

    The American Society of Clinical Oncology (ASCO) has endorsed, with added qualifying statements, Cancer Care Ontario’s guideline on Active Surveillance for the Management of Localized Prostate Cancer.

    Recommended: Collaboration urged in managing ADT-related CV risk

    The guideline, which was published in the Canadian Urological Association Journal (2015; 9:171–178), aims to reduce unnecessary prostate cancer treatment and resulting long-term treatment-related side effects.

    ASCO’s Endorsement Panel reviewed the recent guideline’s content and recommendations. Their report appeared online Feb. 16 in the Journal of Clinical Oncology.

    “Active surveillance should be more commonly used for patients with low-risk prostate cancer, instead of radical prostatectomy or radiation treatment,” lead author Ronald C. Chen, MD, MPH, of the University of North Carolina Lineberger Comprehensive Cancer Center and UNC School of Medicine, said in a UNC press release.

    Also see - PCa studies: Optimized screening, treatment selection essential

    The ASCO panel, which included several urologists, endorsed Care Cancer Ontario’s recommendations that active surveillance is advised for most patients with low-risk (Gleason score 6 or less) localized prostate cancer. The panel endorsed that, when making prostate cancer patient management decisions, urologists and other providers should take into account patients’ age, prostate cancer volume, preference, and ethnicity. This is because prostate cancer is more likely to progress with active surveillance in younger patients, African-Americans, and men with high-volume cancer in the prostate. Providers may offer the option of active surveillance to select patients with low-volume, intermediate-risk (Gleason 3+4=7) prostate cancer.

    Next: Stacy Loeb, MD, MSc, comments on endorsement

    Lisette Hilton
    Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results